In Chengalpattu, about 70 km from the southern Indian city of Chennai, is a cluster of buildings spread over 100 acres. These house manufacturing lines, quality-control lines and other units, all set up to manufacture vaccines. This is the Integrated Vaccine Complex (IVC)—the Indian government’s one-stop solution to be self-reliant in producing vaccines to feed its national immunisation programme. A plan into which it has pumped about Rs 600 crore ($84.28 million) so far.
India’s bootless vaccine plans in the face of HLL’s divestment
The Indian government had big plans of moving away from private sector-produced vaccines. In seven years, it's pumped about Rs 600 crore into a project involving condom-maker HLL Lifecare, with the costs now shooting up to over Rs 900 crore. Just for setting up. Ironically, not a single vaccine has been manufactured so far
Seven years back, the Indian government asked condom-maker HLL Lifecare to make vaccines for the national programme
HLL Biotech, the vaccine arm of HLL Lifecare, has no R&D unit yet, essential for vaccine-making
Experts fear India's grand plan of self-reliance in vaccines is being reduced to a packaging firm
It has been more than a year since HBL requested for funds but to no avail